// App-Quantinova.ai

4591 : Estrogen receptor-positive breast cancer: from genomic landscape to treatment approach

Researchers

Presenter

  • Pradip De

Principal Investigators

  • Casey Williams

  • Amy Krie

  • Kirstin Williams

  • Jessica Klein

  • Jennifer H. Carlson

  • Nandini Dey

  • Brian Leyland-Jones

Medical Centers

  • Avera Research Institute, Sioux Falls, SD.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • AKT Serine/Threonine Kinase 2

  • Mouse double minute 2 homolog

  • p53

  • Phosphatidylinositol 3-kinase regulatory subunit alpha

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • Cyclin D1

  • Cyclin dependent kinase inhibitor 1B

  • Cyclin Dependent Kinase Inhibitor 2A

  • Retinoblastoma protein

  • erb-b2 receptor tyrosine kinase 2

  • Liver kinase B1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved